MicroStockProfit.com announces investment report featuring BioElectronics

MicroStockProfit.com announces an investment report featuring BioElectronics Corp. (Pink Sheets:BIEL). The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.

The full report is available at: www.microstockprofit.com/ads/BIEL

BioElectronics Corp. (BIEL) designs, develops and markets a variety of drug-free, anti-inflammatory patches for a range of medical indications. The Company's patch products, which are marketed under the name ActiPatch Therapy, deliver pulsed electromagnetic field therapy, an anti-inflammatory and pain relief therapy. The ActiPatch Therapy products combine a miniaturized microchip, power source and antenna in a soft, flexible outer envelope. When applied to the body, these devices deliver a pulsed radio frequency signal into the body on a 27 megahertz (MHz) frequency wave that induces a low frequency electromagnetic field to damaged cell tissue.

Message Board Search for BIEL: http://www.boardcentral.com/boards/BIEL

In the report, the analyst notes:   

"BIEL, the maker of inexpensive, disposable drug-free anti-inflammatory devices, recently announced the launch of a second major direct response television sales campaign.

"Beginning last week, the Company began advertising its ActiPatch® brand of drug-free, anti-inflammatory devices, designed to treat back, knee, elbow and foot pain. The 120-second ads are now being run in selected markets, with wide scaled broadcast expected over the coming weeks."

SOURCE MicroStockProfit.com

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Xanthones show promise in diabetes with antioxidant and anti-inflammatory properties